Mark Patrick Guerin - 10 Jun 2024 Form 4 Insider Report for Traws Pharma, Inc. (TRAW)

Role
CFO
Signature
/s/ Mark Guerin
Issuer symbol
TRAW
Transactions as of
10 Jun 2024
Net transactions value
-$1,044
Form type
4
Filing time
20 Jun 2024, 16:25:24 UTC
Previous filing
15 Mar 2024
Next filing
10 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TRAW Common Stock Options Exercise +5,500 +15% 41,476 10 Jun 2024 Direct F1
transaction TRAW Common Stock Tax liability $1,044 -2,221 -5.4% $0.4700 39,255 18 Jun 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TRAW Restricted Stock Units Options Exercise $0 -5,500 -50% $0.000000 5,500 18 Jun 2024 Common Stock 5,500 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert into common stock on a one-for-one basis.
F2 On June 10, 2022 the reporting person was granted 16,500 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary